FierceBiotech
Media & Internet · Missouri, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1001 NW Technology Dr, Lees Summit, Miss...Website
www.fiercebiotech.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About FierceBiotech
Fierce Biotech is a leading source of news and reports focused on the biotechnology sector, covering topics such as clinical data, cell and gene therapy, and venture capital. The company provides insights into the latest developments in medtech, diagnostics, and biologics, catering to professionals in the life sciences industry. It also hosts events, webinars, and awards to recognize innovation and excellence in healthcare and science. Fierce Biotech aims to inform and connect stakeholders in the biotech community, including researchers, investors, and healthcare professionals.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is FierceBiotech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once FierceBiotech has new funding data
Check if FierceBiotech has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when FierceBiotech launches new products
Congratulate Masked Content for being promoted to Masked Content at FierceBiotech
Website visits: Recent activity has been detected on your website
Check out if FierceBiotech is spiking on competitors!
FierceBiotech, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on FierceBiotech recently announced quarterly report
Click to see if FierceBiotech had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined FierceBiotech as Masked Content
Find 2 more new buyers
Compare Similar Companies to FierceBiotech
Compare insights from companies similar to FierceBiotech, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
FierceBiotech
<$5M
1-10
Private
-
2008
N/A
Company Profile Activity
Activity Insights
FierceBiotech is experiencing very low activity levels compared to other companies in the Media & Internet sector.
What does this means?
FierceBiotech is drawing exceptional interest within the Media & Internet industry, suggesting notable developments or strong market momentum, learn more about FierceBiotech.
FierceBiotech Tech Stack
A closer look at the technologies used by FierceBiotech
FierceBiotech News & Media
Questex’s Fierce Biotech Expands Global Footprint, Launches Inaugural Fierce Biotech Event at London Life Sciences Week
One-Day Forum at The Savoy to Unite Global Biotech, Pharma, and Investment Leaders One-Day Forum at The Savoy to Unite Global Biotech, Pharma, and Investment LeadersFierce Pharma Asia—Astellas' stem cell therapy rethink; GSK's bullish ADC plan; Daiichi's OTC sale
Astellas will close a stem cell therapy site. GSK is pushing a Hansoh Pharma-partnered ADC into multiple phase 3 trials. | Astellas will close a stem cell therapy site. GSK is pushing a Hansoh Pharma-partnered ADC into multiple phase 3 trials. Daiichi Sankyo is selling its consumer health business unit for about $1.55 billion. And more.Questex’s Fierce Biotech Announces 2026 Fierce Outsourcing Award Winners, Honoring Excellence Across the Drug Development Ecosystem
NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- Questex’s Fierce Biotech today announces the winners of the 2026 Fierce Outsourcing Awards, recognizing the companies and teams driving innovation, performance, and partnership across the outsourced drug development landscape.Sensei Biotherapeutics Merges with Faeth Therapeutics, Secures $200M Funding
Only a couple of months ago, Sensei Biotherapeutics was laying off staff and mulling winding down the company. But the biotech has found a new lease on life—and a new lead drug—via a merger with Faeth Therapeutics. Shareholders of privately owned Faeth will own 40.8% of the merged company, while Sensei's current shareholders will own 4.9%. The rest will be owned by investors that participated in a $200 million private placement.
Read more news
Top Media & Internet Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding FierceBiotech
Sign Up For FreeTo access detailed company insights
Fierce Biotech is a leading source of news and reports focused on the biotechnology sector, covering topics such as clinical data, cell and gene therapy, and venture capital. The company provides insights into the latest developments in medtech, diagnostics, and biologics, catering to professionals in the life sciences industry. It also hosts event... Read More
